À̴뼿ﺴ¿ø 2020³â Á¦10ȸ ´ëÇÑÇ÷¾×ÇÐȸ Àç»ýºÒ·®ºóÇ÷ ¿¬±¸È¸ ½ÉÆ÷Áö¾ö : 2020-01-18±³À°ÀÏÀÚ : 2020-01-18
±³À°Àå¼Ò : À̴뼿ﺴ¿ø ÁöÇÏ2Ãþ ´ë°´ç
±³À°ÁÖÁ¦ :
2020³â Á¦10ȸ ´ëÇÑÇ÷¾×ÇÐȸ Àç»ýºÒ·®ºóÇ÷ ¿¬±¸È¸ ½ÉÆ÷Áö¾öÁÖÃÖ±â°ü : ´ëÇÑÇ÷¾×ÇÐȸ
½ÃÇà±â°ü(ÁöºÎ/°ú) : Àç»ýºÒ·®ºóÇ÷¿¬±¸È¸
´ã´çÀÚ : À¯¿µÀÓ
¿¬¶ôó : 02-2650-5063
À̸ÞÀÏ :
emhcrc@gmail.com ±³À°Á¾·ù : ³»°ú, ¼Ò¾Æû¼Ò³â°ú, Áø´Ü°Ë»çÀÇÇаú
Âü¼®¿¹»óÀοø : 80¸í
Èñ¸ÁÆòÁ¡ : 5Á¡
Áö¿ª :
¼¿ïƯº°½Ã±³À°½Ã°£ : 5 ½Ã°£ 30ºÐ
¼¼ºÎ¼ö°·á : 0¿ø
ºñ°í
±¸ºÐ ¿ùÀÏ °ÀÇ½Ç ½Ã°£ ±³À°Á¦¸ñ °»ç¸í(¼Ò¼Ó) Çʼö°ú¸ñ
±³À°½Ã°£ 01-18 ´ë°´ç 09:40~10:00 Recent research update 2019 (1) º¯ÀÚ¹Î(¼¿ïÀÇ´ë)
±³À°½Ã°£ 01-18 ´ë°´ç 10:00~10:20 Recent research update 2019 (2) ¹Ú¹Ì¸²(±¹¸³¾Ï¼¾ÅÍ)
±³À°½Ã°£ 01-18 ´ë°´ç 10:20~10:40 ASH 2019 guidline for ITP ÀÌÁöÇö(µ¿¾ÆÀÇ´ë)
±³À°½Ã°£ 01-18 ´ë°´ç 10:55~11:25 Recent advances of treatment aplastic anemia ÀåÁØÈ£(¼º±Õ°üÀÇ´ë)
±³À°½Ã°£ 01-18 ´ë°´ç 11:25~11:55 HSCT for the patients of aplastic anemia À¯°ÇÈñ(¼º±Õ°üÀÇ´ë)
±³À°½Ã°£ 01-18 ´ë°´ç 11:55~12:25 Recent advances of pure red cell aplasia, pure white cell aplasia and acquired amegakaryocytic thrombocytopenia ¼ÛÀÍÂù(Ãæ³²ÀÇ´ë)
±³À°½Ã°£ 01-18 ´ë°´ç 13:40~14:10 Treatment of PNH: eculizumab and new agents ±èÇõ(°¡ÃµÀÇ´ë)
±³À°½Ã°£ 01-18 ´ë°´ç 14:10~14:40 Recent advances of atypical HUS ±èÁø¼®(¿¬¼¼ÀÇ´ë)
±³À°½Ã°£ 01-18 ´ë°´ç 14:40~15:10 Recent advances of TTP ¹è¼ºÈ(´ë±¸°¡Å縯ÀÇ´ë)
±³À°½Ã°£ 01-18 ´ë°´ç 15:25~15:55 Recent approach for cold agglutinin disease ¹®¿µÃ¶(ÀÌÈÀÇ´ë)
±³À°½Ã°£ 01-18 ´ë°´ç 15:55~16:25 Role of antifungal agents for hematologic disorders ±èÃæÁ¾(ÀÌÈÀÇ´ë)
±³À°½Ã°£ 01-18 ´ë°´ç 16:25~16:55 Providing or removing of iron for hematologic disorders ¹Ú¿µÈÆ(°¡Å縯ÀÇ´ë)